Astrazeneca's Trial, Schott Pharma Up, Rheinmetall Sinks episode artwork

EPISODE · Jul 9, 2026 · 4 MIN

Astrazeneca's Trial, Schott Pharma Up, Rheinmetall Sinks

from Stock Movers · host iHeartPodcasts

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- AstraZeneca and Ionis Pharmaceuticals Inc.’s gene silencer drug Wainua failed to help prevent heart problems in patients with a rare and potentially fatal disease of the organ. AstraZeneca’s shares slumped.- Schott Pharma shares jump by a record 22% after the company improved its guidance for the full year, prompting an upgrade at RBC Capital Markets. The stock is trading at its highest level since October. - Bulgaria’s government may not be able to secure funding for joint project with Rheinmetall for NATO-standard shell, gunpowder plant, Mediapool news website reports, citing Economy Minister Alexander Pulev.See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Jul 9, 2026

Embed this episode

NOW PLAYING

Astrazeneca's Trial, Schott Pharma Up, Rheinmetall Sinks

0:00 4:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Stock Movers?

This episode is 4 minutes long.

When was this Stock Movers episode published?

This episode was published on July 9, 2026.

Can I download this Stock Movers episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!